Table 3:
Magnitude (Magn) of amplitude tremor (as percent modulation) and magnitude of frequency tremor (as percent modulation): group means, standard deviations (SD), F-statistics and P values with and without baseline (BL) covariance adjustment (alpha <0.05). Means include data from Baseline 1 and 2 and Post-test 1 and 2 for each drug phase.
|
Magn
of Amplitude Tremor |
SD |
F value
(with BL covariance) |
P value
(with BL covariance) |
F value
(without BL covariance) |
P value
(without BL covariance) |
|
|---|---|---|---|---|---|---|
| Octanoic acid | ||||||
| Baseline | 13.49 | 6.48 | ||||
| Post-test | 9.35 | 5.42 | ||||
| Placebo | ||||||
| Baseline | 12.91 | 6.46 | ||||
| Post-test | 12.43 | 7.37 | ||||
| Statistical Results | 4.69 | 0.0499* | 6.68 | 0.0216* | ||
|
Magn of
Frequency Tremor |
SD |
F value
(with BL covariance) |
P value
(with BL covariance) |
F value
(without BL covariance) |
P value
(without BL covariance) |
|
| Octanoic acid | ||||||
| Baseline | 5.19 | 3.58 | ||||
| Post-test | 3.98 | 2.94 | ||||
| Placebo | ||||||
| Baseline | 5.57 | 4.29 | ||||
| Post-test | 5.35 | 3.76 | ||||
| Statistical Results | 4.85 | 0.0450* | 5.53 | 0.0339* | ||